Halyard Health, Inc. (NYSE:HYH) reported Q2 2017 earnings this Morning, coming in at $0.51 per share, beating Wall Street’s estimates of $0.37 per Share. Revenue for the quarter came in at $399.20 million beating analyst estimates of $399.16 million
Analyst Coverage For Halyard Health, Inc. (NYSE:HYH)
These are 3 Hold Ratings, 1 Buy Rating .
The current consensus rating for Halyard Health, Inc. (NYSE:HYH) is Hold (Score: 2.25) with a consensus target price of $39.33 , a potential (1.40% downside)Recent Insider Trading for Halyard Health, Inc. (NYSE:HYH)
- On 9/4/2015 Robert E Abernathy, CEO, bought 10,000 with an average share price of $31.06 per share and the total transaction amounting to $310,600.00.
- On 9/1/2015 Steven E Voskuil, CFO, bought 1,000 with an average share price of $30.00 per share and the total transaction amounting to $30,000.00.
Recent Trading for Halyard Health, Inc. (NYSE:HYH) Shares of Halyard Health, Inc. closed the previous trading session at 41.11 up +1.22 3.06% with 373,184 shares trading hands.